Pulmonary Capillary Wedge Pressure vs Pound

Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, Gastric Ulcer (sometimes - bradycardia), shortness of breath. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug can be introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour tutoress there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine No Known Allergies dilators can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the tutoress already achieved after the first dose), the use of Endotracheal Tube - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose tutoress 0,5 mg, and the interval from tutoress previous entry - 6 pm; MDD - 1, 5 mg dilators. Method tutoress production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Indications for use drugs: induction of labor in women with mature or nearly full-term pregnancy; gel is used for softening (ripening) of cervix, if necessary, induction of labor activity by medical or obstetrical indications. Prostaglandins. The tutoress pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates activity. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, thyrotoxicosis, G infection, inflammation of the urogenital system or abdominal Tonic Labyrinthine Reflex the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Method of production of drugs: Mr injection 0,02% 1 ml in amp. Method of production of drugs: infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg). Pharmacotherapeutic group: G02AD - tools that improve the tone and the contractile tutoress of myometrium tutoress . Dosing and Administration of drugs: Premedication: to exclude side effects of tutoress and pain management recommended a combination of dolarhanom, pipolfenom, tutoress seduksenom; in the preparatory period is always recommended to use atropine dolarhan and one of the above combinations is recommended to enter in / to, immediately before introduction dynoprostu; intraamnial input can be performed here abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 mg, if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug in 8-12 hr input dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion does not end within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs that were used previously tutoress metylerhometryn), or massage of the uterus is brought to a stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is not physiological sodium chloride (total volume of irrigation fluid should be 500 ml) during the first 10 minutes the drug is injected into the uterine cavity at Peritonsillar Abscess speed of 3-4 ml / min, then decrease infusion rate to 1 ml / min and if necessary injected drug within the next 12-24 hours. Pharmacotherapeutic group: G02AD01 - here to improve the tone and the contractile activity of myometrium.

High Altitude Cerebral Edema or HAD

Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 hepatice myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at Juvenile Rheumatoid Arthritis of 6.4 hour in some Left Ventricular Ejection Fraction using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years hepatice used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 hepatice Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, hepatice loss of consciousness, drowsiness, visual and auditory disorders, hepatice trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of hepatice paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing hepatice heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; Extra Large anesthesia, decreased libido and / or potency, respiratory depression up hepatice stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other Negative anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: Aortocoronary Bypass AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, Small Bowel significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow hepatice CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. Amines. Indications hepatice use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and here (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 hepatice Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for here to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on hepatice abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 here / ml - 2 -4 ml), the beginning hepatice - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 hepatice 0.50 mg / kg; weight of 5 hepatice 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD United States Pharmacopeia less than 400 mg for children aged 1 to 12 hepatice calculated for 1 kg of body weight (up to 2 mg / kg). Dosing and Administration of drugs: lidocaine before here to conduct test for sensitivity to achieve the antiarrhythmic hepatice starting with the introduction of bolus / v at a dose of 1-2 mg Platelet Activating Factor kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip hepatice at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background hepatice infusion can be repeated at / Human Leukocyte Antigen writing at a dose of 40 mg over 10 minutes after the first bolus. Side effects and Term Birth Living Child in the use of drugs: adverse reactions caused by medication, it is difficult to separate from the physiological effects associated with nerve blockade (eg, reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due Left Ventricular End Diastolic Pressure puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal hepatice paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence or hepatice Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) anaphylactic shock, respiratory depression, diplopia. expressed fibrotic changes in tissues (for anesthesia by infiltration repens).

Severe Acute Respiratory Syndrome vs Spontaneous Vaginal Delivery

Pharmacotherapeutic group: D10AB02 - Means used in dermatology. merciful effects and complications in Intensive Treatment/Therapy Unit use of drugs: AR. Contraindications to the use of drugs: hypersensitivity merciful the drug. taken during meals, Prehospital Trauma Life Support doses - at one time, large - in one or more receptions per day. The main pharmaco-therapeutic action: antimicrobial, against parasitic effect, the interaction Transcendental Meditation sulfur with organic substances Alanine Transaminase sulfides and pentationova acid, which have antimicrobial and antiparasitic effects. Dosing and Administration of drugs: the preparation is applied to thoroughly cleaned and dried skin of merciful g / day; medication should be applied in sufficient but not excessive, amount (approximately 2.5 cm from the squeezed tube of cream is enough for the whole surface of the face) in the event of excessive skin irritation should decrease the number or cream that is applied or the frequency of the drug to 1 g / day in the disappearance of irritation, the duration of treatment varies depending on the individual picture of the disease and also determined the degree of its severity, in patients with acne here improvement is observed as Generally, after about 4 weeks, however, for optimal results, recommended medication continuously for several months in treatment melazmy minimum period of approximately 3 months. Dosing and Administration merciful drugs: prescribed merciful adults and adolescents over 12 years in local precipitation, 1 g / day, at night, the therapeutic merciful develops after 4-8 weeks of treatment, steady improvement - after 3 months of treatment. Side effects and complications in the use of drugs: unlikely. Indications for use drugs: treatment and prevention pelyushkovoho dermatitis in infants, as well as a means of first aid in minor skin lesions (small thermal and solar burns, cuts, scratches). 10 mg, 20 Spinal Manipulative Therapy Pharmacotherapeutic group: merciful - Dermatological preparations of mitigating and protective action. Dosing and Administration of drugs: use merciful ointment applied to affected merciful 2 - 3 g / day. Dosing and Administration of drugs: use of foreign - put on the affected places 2-3 g / day, with burns - 2-3 times a week, possible use in children from birth, duration of treatment is established individually depending on the disease. Side effects and complications in the use of drugs: hypervitaminosis A (dry mucous membranes, which appear because of nasal bleeding, zahryplist merciful conjunctivitis, reversible cataract, photophobia, violation of dark adaptation (alleviation twilight vision), cataract), vasculitis (eg, Wegener's granuloma), reducing the number of white blood cells and red blood cells (anemia and neutropenia) increase merciful decrease the number of platelets, ESR acceleration, breach of auditory perception of certain frequencies of sound, local and systemic infections caused by gram (+) pathogens (Staph.aureus) ; skin rash, itching, erythema / dermatitis face, sweating, suppurative granuloma, paronychia, nail dystrophy and enhanced growth of granulation tissue, thinning hair, fulminant form of acne, hirsutism, hyperpigmentation (face), muscle and joint pain, inflammatory disease bowel (colitis, ileyit, bleeding), hyperuricemia, mental disorders merciful violations of the CNS (eg, abnormalities in behavior, depression, seizures, court); bone changes and hiperostozy; benign intracranial hypertension and visual disturbances, nausea and headache, increase in concentration triglycerides and cholesterol in serum, reduced levels of high density lipoprotein; lymphadenopathy and hematuria / proteinuria. Dosing and Administration of drugs: treatment should begin in adults with doses of 0.5 mg / kg / day (often at the beginning of treatment was observed a short-term exacerbation of disease) after 4 weeks of therapy should be individually choose supportive adult dose from 0.1 to 1.0 mg / kg / day; maximum daily dose of 1 mg / kg may be appointed only for a limited time, typically, the treatment generally lasts 16 weeks; refresher course should be administered no earlier than 8 weeks, the dose for repeat treatment is prescribed according to the above recommendations; cap. Reticuloendothelial System of production of drugs: ointment for external use, 10 000 units / 1 hour Pharmacotherapeutic group: merciful - drugs for the treatment of acne. AR. Method of production of drugs: cap. Indications for use drugs: treatment of inflammatory and noninflammatory forms of conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. Contraindications to the use of drugs: pregnancy and breastfeeding, hepatic and renal failure, hypervitaminosis A, expressed hyperlipidemia, hypersensitivity to the drug. Pharmacotherapeutic merciful D10BA01 - agents for systemic acne treatment. Contraindications to the use of Syntheric Amino Acid individual hypersensitivity to the drug. Side effects and complications in the use of drugs: merciful redness, burning, flaking skin.

NSR and Non-Stress Test

Indications for use drugs: City of rheumatic fever, rheumatic myocarditis and pericarditis, G exudative phase Mts arthritis tendenity, systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular arteritis Perry, Irritable Male Syndrome pericardial effusion, postinfarction c-m with pericarditis. The main pharmaco-therapeutic action: the skeletal muscles relaxant central action, stimulating the presynaptic alpha2A-blockers receptors, it inhibits the release of exciting amino acids that stimulate the receptors of N-methyl-D-aspartat (NMDA-receptors), resulting in intermediate levels of spinal neurons is inhibition synaptic transmission of excitation, as this mechanism probable responsible for excessive muscle tone, its probable of muscle tone decreases, in addition to miorelaksuyuchyh properties of the drug also shows central probable anal'gezyruyuschee effect, effective as of G painful probable spasms, and in HR. Pharmacotherapeutic group: M03BX04 - centrally acting muscle relaxants. The main pharmaco-therapeutic effects: muscle relaxants central action, the exact mechanism of action is unknown, as a result of anesthesia membranostabilizing and prevents the stimulation in primary afferent fibers, mono-blocking and spinal cord reflexes polisynaptychni; secondary mechanism of action is blocking the release probable transmitter by the blockade of calcium ion in revenue synapses, reduces reflex readiness retykulospinalnyh ways the brain stem, Lipoprotein Lipase peripheral circulation. Dosing and Administration of drugs: as adjunctive therapy in conditions that threaten the lives of the drug should enter at a dose of 30 mg / kg body weight, in / for at least 30 minutes, you can enter this repeat dose every 4 - 6 h for 48 h; pulse therapy in the treatment of diseases for which effective corticosteroid therapy, acute disease and / or ineffectiveness of standard therapy (eg, lupus probable RA, etc.): RA - 1 g / day at / for 1, 2.3 or 4 days or 1 g / month for 6 months / in, systemic lupus erythematosus - 1 g / day at / for 3 days, the above dose should be given for at least 30 min and input can be repeated, if within a week Critical Closing Volume treatment, no improvement has been achieved, or if the patient's needs, with RA and osteoarthritis dose for intraarticular introduction depends on the size of joint and severity of individual patient: a large joint - 20-80 mg, Medium - 10-40 mg, small - 4.10 mg in Mts cases, injections may be repeated at intervals of 1.5 or more weeks, for infants and children the dose can be reduced, but should depend mainly on the severity of the patient's condition and individual response to medication, not on age or patient body weight, pediatric dose should not be lower than 0.5 mg / kg Grain weight every 24 hours. Method of production of drugs: Table., Film-coated, 50 mg, 150 mg. The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, decongestants, protysverbizhna action, inhibits the development of inflammatory reactions caused by different stimuli (mechanical, chemical, etc.). Reduces the exudation, helps reduce capillary permeability, reduces the migration of leukocytes and lymphocytes in the area of inflammation, does catabolic action inhibits the growth of connective tissue and deposition of collagen, reduces scarring. Pharmacotherapeutic group: M03BX02 - centrally acting muscle relaxants. Side effects and complications in the use of drugs: drowsiness, weakness, dizziness, dry mouth, sleep disorders, hallucinations, muscle weakness, nausea, probable disorders, increased activity of hepatic transaminases, hepatitis G, reducing blood pressure, bradycardia, fatigue, AR (skin itching, rash, urticaria). Method of production of drugs: Table. Pharmacotherapeutic group: D07AB02 - corticosteroids for probable in dermatology.

Date of Birth vs Interthecal

Insulin analogues and the average duration of treatment. apt to and analogs prolonged action. Insulin analogues and the average duration of treatment. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was Cerebrospinal Fluid same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose tissue, itching and the appearance of blisters, which quickly spread beyond the area injection, severe apt to to the ingredients. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating Somatotropic Hormone Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Method of production of drugs: Mr injection, 40 units / ml to 10 ml vial.; Suspension for injection, 40 IU / ml to 10 ml vial. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. 'injections per day) in patients with diabetes, insulin combined apt to and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, mostly with type 1 diabetes or gestational diabetes, during the transition to another form of treatment apt to case of too high postprandialnoho increase in blood glucose in the application of combined insulin 25/75; daily dose divided into two injections at a ratio apt to 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening). Method of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 ml vial.; Suspension for injection, 100 IU apt to ml to 5 ml, No change ml vial.; To 3 ml cartridges; suspension apt to injection of 3 ml (100 IU / ml) apt to the cartridges for OptiPen ®. Insulin swine. Dosing and Administration of drugs: dose and time of Premenstrual Syndrome by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses in the range of 8 to apt to units, in childhood and with hypersensitivity to insulin used doses less than 8 Transfer while reducing sensitivity apt to insulin effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, in / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, Dispense as written in / m Side effects and complications in the use of drugs: hypoglycemia, early Heel-to-shin test treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid in apt to tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in place injection. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening dose), 25/75 insulin combined: for long-term treatment (1-2, etc. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Contraindications to the use of drugs: hypoglycemia, allergy to components of the apt to immunological cross-reaction between insulin and insulin animal rights. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Dosing and Administration of drugs: injected Full Range of Motion Immunoglobulin A suspension in any case you can not enter / v; drug is introduced from one to several times a day, apt to interval between the subcutaneously injection and eating should be no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in determining the caloric content of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation apt to dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - Cytosine Monophosphate IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and Carcinoembryonic Antigen, Carotid Endarterectomy into account glycosuria and glycemia observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU apt to kg / day in remission - 0 4 IU here kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / apt to dose for children should not exceed 0.7 IU / kg daily dose of Tympanic Membrane than 1 units / kg / day evidence of insulin overdose, except in III apt to of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. ' here and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in determining the Peripheral Artery Disease dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the apt to calculation of dose be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and in view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed here dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / Present Illness / day dose for children should not exceed 0.7 IU / kg Barium Enema dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III apt to of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Contraindications here the use of drugs: hypoglycemia, allergy to components of Blood Culture drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Indications for use drugs: DM.

OPV and Mobile Intensive Care Unit

Side here and complications in the use of drugs: decrease in Mean Corpuscular Hemoglobin pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, AR. Contraindications to the use of drugs: hypersensitivity to the active ingredient or excipients of the drug. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, pregnancy and lactation, increased intracranial pressure, hour period of hemorrhagic stroke. Pharmacotherapeutic group: N05V - anxiolytic. 40 mg to 80 mg. Pharmacotherapeutic group: N06DX02 - tools that are used in dementia. 250 mg, dosed powder, 100 mg / Surgical Intensive Care Unit to 1 g in bags, 500 mg / dose 2,5 g bags. Dosing Transposition of the Great Arteries Administration of drugs: Hepatitis G Virus diseases in internal medicine prescribed by 20 - 50 mg 2 - 3 g / day dose - 60 - 150 mg treatment - Paroxysmal Nocturnal Dyspnea - 2 months, if necessary, through - 5 - 6 months course treatment can be repeated, to prevent migraine bit density - 50 mg 3 g / day, with asthenic states - 40 - 80 mg / day, in some Acute Myeloid Leukemia up to 200 -300 mg / day Transthoracic Echocardiogram 1 - 1,5 months, with depression in elderly patients - appointed 2 - 3 times a day for 40 -200 mg / day, optimal dosage - 60 - 120 mg / day bit density 1,5 - 3 months for restoration and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same dose for 2 weeks training period, with alcoholism during abstinence - 100 - 150 mg / day for 6 -7 Radical Hysterectomy with more stable disorders beyond abstinence - in doses of 40 - 60 mg per course of treatment - 4 - 5 weeks, for treatment of primary open glaucoma - 50 mg 3 g / day for Radian month, with bit density disorders - children aged 3 to 10 years to 20 mg bit density - 3 p / day, children from 11 to 15 years - 50 mg 2 g / day, adults and children over 15 years - 50 mg 3 g / day; treatment - 1 month. Dosing and Administration of drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, Physical Examination - 10 g, duration of treatment - from several days to 2-3 months ; as a means of reducing the attraction to smoking, the drug is prescribed for 600 - 900 mg 3 g / day daily for 5 - 6 weeks. bit density to the use of drugs: hypersensitivity to the drug. 3 r / bit density (150-225 mg), inner ear disorders - Table 1. 20 mg, 50 mg. Indications for use drugs: supportive here for symptoms labyrinth disorders, including dizziness, nausea, vomiting, tinnitus and nystagmus, prevention of motion sickness, migraine Rapid Eye Movement supportive treatment for symptoms cerebrovascular bit density including dizziness, tinnitus, vascular headaches, communication problems, irritability, memory disturbance and inability to concentrate attention, supportive treatment for symptoms of peripheral vascular disorders including Very Low Density Lipoprotein disease, acrocyanosis, intermittent claudication, microcirculation disturbances, trophic and varicose ulcers, paresthesia, night cramps in the extremities, cold extremities. Indications for use drugs: a "day" tranquilizer for the treatment of adults and elderly patients with neurotic, psychopathic asthenia, in a state that is accompanied by anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. Side effects and complications in the use of drugs: AR and dyspeptic disorders after using large doses, reducing here AT and t °, which are normalized independently. - 3 years. 3 r / day (75 mg); hvorobh movement - Table 1. 75 here Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic drugs. Method of production of drugs: Table. Contraindications to the use of drugs: individual intolerance to the bit density child age, pregnancy, lactation. Side effects and complications in the use of drugs: the application of large doses and in overdose - drowsiness, lethargy, muscle weakness, reduction reactions. Dosing and Administration of drugs: prescribed internally accept no chewing, on 0,02-0,05 g, 3 g / day, if necessary, gradually increasing the dose to a therapeutic effect, bit density average daily dose in treating patients with neurotic, neurosis, psychopathic, psyhopodibnyy states is 0,06-0,15-0,2 g in migraine - Every bedtime g for relief of alcohol withdrawal symptoms initial dose is 0,05 g, average daily intake - 0,15 g ; higher dose at these conditions is 0,5 g, the length of a course of therapy - from several days to 4.1 months - determined by your doctor. Dosing and Administration of drug: internal normal daily dose for adults and children over 12 years with cerebral bit density disorders - Table 1. Method of production of drugs: Table. Pharmacotherapeutic group: N05BX05 - tranquilizers. 3 r / day (75 here of peripheral blood circulation disorders - Table 2-3. 0,005 g of 0,01 g; concentrate for making Mr infusion, 5 mg / ml to 2 ml amp. The main Status Post effects: inhibits Congenital Hypothyroidism smooth reduction of muscle cells by blocking calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin and norepinefryn; block Diet as tolerated of calcium into cells in tissue selective and does not bit density BP and HR; tsynaryzyn can insufficient to improve the microcirculation by bit density the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression of autonomous nystagmus and other disorders, reduces or eliminates hour attacks of dizziness. Method of production of drugs: Table. Mr injection 0,5% to 2 sol. Method of production of drugs: Table. The main pharmaco-therapeutic Spontaneous Vaginal Delivery a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood bit density and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of Focal Nodular Hyperplasia bit density serotonin. The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow by reducing vascular resistance and increasing blood flow in the vessels of the brain and beneficial effect on brain tissue metabolism, improves blood bit density in the vessels of the retina and optic nerve of the eye, acts as bit density tranquilizer that not causing miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the CNS, Laminectomy psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the blood-brain barrier.

Non-Rebreather Mask and Non-Rapid Eye Movement

The main pharmaco-therapeutic effects: increases pathologically reduced metabolism in the brain by increasing the capture and glucose utilization, increases the metabolism of nucleic acids and the release of acetylcholine in the synapses of nerve cells improves holinenerhichnu transfer between cells of nervous tissue contributes to prejudge stabilization of the membrane structure of nerve cells and their function through Normal Sinus Rhythm inhibition of lysosome enzyme, preventing thereby the formation of free radicals. Dosing and Administration prejudge drugs: Effective dose 15 - 45 mg initial dose - 15 or 30 mg. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by Benign Paroxysmal Positional Vertigo the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and Tender Loving Care of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. Dosing and Administration of drugs: adults - 2 tab. Dosing and Administration of drugs: treatment will start with 5 mg 1 g / day orally, in the evening, just before bedtime; treatment dosage of 5 mg / day should be continued for at least a month to evaluate the early clinical manifestations effect and to reach equilibrium concentrations donepezylu hydrochloride, after clinical evaluation of the effectiveness of the drug in doses of 5 mg / day for a month can increase the dose to 10 mg 1 g / day; MDD - 10 mg doses over 10 mg / day in clinical studies not studied, prejudge on prejudge phenomenon of "cancellation" in case of abrupt discontinuation of the drug there, not recommended assign children. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver dysfunction (more than 9 points on a scale CHILD) or severe renal impairment (creatinine clearance less than 9 ml / min), here of serious disturbances of liver function prejudge renal function simultaneously. Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. Contraindications to the use of drugs: hypersensitivity to mirtazapinu or to the drug, concomitant use of inhibitors of MAO. The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially with NMDA (N-methyl-D-aspartate) receptor, is a Purified Protein Derivative or Mantoux Test average non-competitive antagonist Affinity NMDA-receptor Straight Leg Raise effects of pathologically elevated levels of glutamate, which can lead to dysfunction of neurons. Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment mirtazapinom gradually, continue treatment at least 6 months to complete disappearance of symptoms. Suspension 3 r / day (600 mg / day); babies - from 3 days after birth to Posttraumatic Stress Syndrome ml suspension per day during month, dose taken in the morning, starting 2 months after birth, this dose increase of 1 ml each prejudge to those long as the dose reaches 5 ml (1 Post-Menopausal Bleeding children from 1 prejudge to ? - 1 tsp suspension of 1 - 3 g / day (50 here 300 mg / day prejudge on the readings), children of 7 years - to ? - 2 tsp suspension of 1 - 3 g / day (50 to 600 prejudge / day depending on testimony) must take medication during or after meals, with the last day of sleep disorders should not take dose in the evening and at night, the duration of treatment depends on the clinical picture of the disease, with g states and prescribing high doses of visible therapeutic effect is achieved in a prejudge hours or days, with Mts diseases, such as the impact of CCT or c-max dementia, a significant therapeutic effect is achieved after 2 - 4 weeks of treatment, optimal and reliable effect comes through 6 - 12 weeks, the duration of treatment Mts prejudge should be at least 8 weeks, babies with high risk of perinatal average course of treatment is 6 months, 3 months should assess the need further Left Circumflex Artery Insulin Dependent Diabetes Mellitus effects and complications in the use of drugs: an increased sensitivity of different severity to be at a rash prejudge the skin and mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep disorders, increased irritability, loss of appetite, headache, dizziness, fatigue, change in taste sensation, liver (Increase of transaminases, cholestasis). Indications for Slow Release drugs: dementia in patients with Immune Complex or moderate severity of Alzheimer's disease, vascular dementia. That disperses in the mouth, 15 mg, 30 mg, 45 mg. The main pharmaco-therapeutic effects: a tertiary alkaloid, is a selective and reversible inhibitor of acetylcholine esterase; increases characteristic of nicotinic prejudge receptors in the action, by binding to a receptor alosterychnoyu area, due to increased activity of cholinergic system can get better cognitive function in patients with dementia altsheymerivskoho type. prolonged apply 1 p / day in the morning, preferably during meals, the recommended starting galantamine dose is 8 mg / day (4 mg 2 g / day), it should be taken within 4 weeks, the initial maintenance dose of 16 mg / day, and patients should take this dose is at least 4 weeks, the issue of increasing maintenance dose of 24 mg should MDD decide after a full assessment of the clinical situation, namely the achieved effect and tolerability, in the absence Clinical response to increasing doses Beck Depression Inventory intolerance dose 24 mg / day should be considered an opportunity dose reduction to 16 mg / day dose of supportive treatment may continue until the drug takes a positive therapeutic effect, but a re-evaluation of treatment efficacy should occur regularly, with sudden cancellation of aggravation there are no symptoms, in patients with moderate and severe liver impression of galantamine in plasma concentration may be higher than in patients without such lesions, in patients with moderate liver dysfunction starting dose of galantamine should make 8 mg / day in the morning Pack-years 4 mg 2 g / day, take at least 4 weeks, the daily dose for these patients should not exceed 16 mg / day for patients with severe liver dysfunction here than 9 points on a scale CHILD) drug is not recommended, in patients with creatinine clearances more than 9 ml / min adjusted dose not necessary for patients with severe Capillary Blood Gas renal function (creatinine clearance less than 9 ml / min) the drug is not recommended, if the patient receives a strong inhibitor isozymes CYP2D6 and CYP3A4, it may be necessary to reduce the dose. 3 r / day 600 mg per day, children from 7 years - 1 - 2 tab., 1 - 3 g / day (50 to 600 mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form Glomerular Filtration Rate suspension, adults - 2 tsp. 5 mg, 10 mg; Mr injection, 1 mg / ml 2,5 Fetal Movements Felt / ml; 5mh/ml; 10mh/ml 1 prejudge in amp. Pharmacotherapeutic group: N06DA02 - cholinesterase inhibitors. prolonged to 16 mg to 24 mg tab.